glp 1 leg pain A new approach to peripheral artery disease Ozempic for Arthritis? GLP-1 Agonists
Description
Biosimilar development requires significant investments that occur years before a biosimilar drug launches
This makes them invaluable, especially for chronic conditions
Pramlintide is the first synthetic amylin analogue that approved for diabetes management with WL up to 7.9% [86]
The benefits of exenatide therapy were retained after the 12-week washout period, wherein patients on exenatide had a significant retention of motor function compared with the control group
